mots-c with retatrutide Peptide Therapy CT MOTS-c 10mg — Mitochondrial-Derived Research

Glatter: When response remains limited despite optimization, clinicians should consider moving beyond monotherapy

45 , S57s102 (2020)

[16] The therapeutic arm taking 500 mg green tea extract three times daily for 16 weeks showed increased GLP-1 levels that were not observed in the placebo group

2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

In terms of Deviations from the intended interventions (D2), one study presented a high risk of bias (50), while two studies indicated some concerns (41, 51)

The company focuses on medical care with behavior change, per the brands site